A detailed history of Lokken Investment Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lokken Investment Group LLC holds 4,199 shares of LLY stock, worth $3.56 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares
4,199
Previous 4,536 7.43%
Holding current value
$3.56 Million
Previous $3.53 Million 7.74%
% of portfolio
1.86%
Previous 1.83%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $244,281 - $306,346
-337 Reduced 7.43%
4,199 $3.8 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $132,652 - $177,470
-224 Reduced 4.71%
4,536 $3.53 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $1,738 - $2,397
-4 Reduced 0.08%
4,760 $2.56 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $53,663 - $71,753
-153 Reduced 3.11%
4,764 $2.23 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $29,509 - $34,657
-95 Reduced 1.9%
4,917 $1.69 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $22,830 - $26,601
71 Added 1.44%
5,012 $1.83 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.02%
4,941 $1.6 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $29,545 - $34,690
-106 Reduced 2.1%
4,940 $1.6 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $9,387 - $11,666
40 Added 0.8%
5,046 $1.47 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $87,241 - $108,267
388 Added 8.4%
5,006 $1.38 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $27,478 - $33,816
-124 Reduced 2.61%
4,618 $1.07 Million
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $180 - $233
1 Added 0.02%
4,742 $1.09 Million
Q1 2021

Jun 10, 2021

SELL
$164.32 - $212.72 $68,850 - $89,129
-419 Reduced 8.12%
4,741 $886,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $54,662 - $72,331
419 Added 8.84%
5,160 $871,000
Q1 2012

Apr 13, 2021

BUY
N/A
4,741
4,741 $886,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lokken Investment Group LLC Portfolio

Follow Lokken Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lokken Investment Group LLC with notifications on news.